Imis Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in Vijayawada (Urban), Andhra Pradesh, India, established in 1981.
1981 Vijayawada (Urban), Andhra Pradesh, India Active
Last Updated:
Access Report
About Imis Pharmaceuticals Private Limited

Imis Pharmaceuticals Private Limited, a active private limited company, was established on 25 June 1981 in Vijayawada (Urban), Andhra Pradesh, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24239AP1981PTC003079. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.

Formerly known as Imis Pharmaceuticals Pvt Ltd. It upholds a compliant status. Employing 158 professional, Its leadership includes Naga Lakshmi Vepakomma (Managing Director), Nagamallika Gudipaty (Director), Nagaprasuna Balantrapu (Director). Past directors included Krishna Vepakomma, Naga Lakshmi Vepakomma, Lakshminarayana Dubagunta. It holds ₹2.76 Cr open charges and ₹1.13 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 30-17-1, Seetharampuramvijayawada -520 002, Vijayawada (Urban), Andhra Pradesh, 520002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239AP1981PTC003079

  • Registration Number

    003079

  • Incorporation Date

    25 June 1981

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹3.00 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 3.00 M
  • Company Age 44 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.76 Cr
  • Satisfied Charges ₹ 1.13 Cr
  • Revenue Growth **** 36.11%
  • Profit Growth **** -20.75%
  • Ebitda **** 110.23%
  • Net Worth 7.47%
  • Total Assets **** 45.22%
Company report

Imis Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Imis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Imis Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Naga Lakshmi Vepakomma Managing Director 01 Apr 1998 Current
Nagamallika Gudipaty Director 12 Jun 2015 Current
Nagaprasuna Balantrapu Director 04 Aug 2017 Current
Dubagunta Nagasaila Director 12 Jun 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 13 Jan 2019 Past
Pramod Abcsdd Director 22 Aug 2020 Past
Pramod Abcsdd Managing Director 13 Jul 2010 Past
Pramod Abcsdd Director 04 Aug 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Imis Pharmaceuticals.

Imis Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 36.11% increase. The company also saw a substantial fall in profitability, with a 20.75% decrease in profit. The company's net worth moved up by a moderate rise of 7.47%.

Imis Pharmaceuticals revenue growth over time
Imis Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 36.11%
*******
*******
*******
*******
Revenue from Operations
*******
 36.09%
*******
*******
*******
*******
Total Assets
*******
 45.22%
*******
*******
*******
*******
Profit or Loss
*******
 -20.75%
*******
*******
*******
*******
Net Worth
*******
 7.47%
*******
*******
*******
*******
EBITDA
*******
 110.23%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Imis Pharmaceuticals?

Unlock access to Imis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹27,642,000.00

Satisfied Charges

₹11,300,000.00

Charges Breakdown by Lending Institutions
  • Indian Overseas Bank : 2.76 Cr
Latest Charge Details
Date Lender Amount Status
15 May 2009 Indian Overseas Bank ₹2.76 Cr Open
15 Dec 2008 Andhra Bank ₹3.00 M Satisfied
20 Jan 2005 Andhra Bank ₹0.65 M Satisfied
28 May 2004 Andhra Bank ₹1.80 M Satisfied
29 Dec 1994 Andhra Bank ₹0.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Imis Pharmaceuticals?

Imis Pharmaceuticals has a workforce of 158 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Imis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imis Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Imis Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Imis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Imis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was recorded as a recent event.

  • Charges

    The activity A charge with Indian Overseas Bank of Rs. 27.64 M registered on 15 May 2009 with Charge ID 10164902 was modified on 06 Oct 2023. was completed.

  • Director Appointment

    The activity Nagaprasuna Balantrapu was appointed as a Director was appointed as a Director on 04 Aug 2017 & has been associated with this company since 8 years 6 months . was completed.

  • Director Appointment

    Nagamallika Gudipaty was appointed as a Director was appointed as a Director on 12 Jun 2015 & has been associated with this company since 10 years 8 months . was recorded as a recent event.

  • Director Appointment

    Progress on Dubagunta Nagasaila was appointed as a Director was appointed as a Director on 12 Jun 2015 & has been associated with this company since 10 years 8 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Imis Pharmaceuticals Private Limited?

The CIN of Imis Pharmaceuticals Private Limited is U24239AP1981PTC003079.

Where is Imis Pharmaceuticals Private Limited headquartered?

Imis Pharmaceuticals Private Limited is headquartered at 30-17-1, Seetharampuramvijayawada -520 002, Vijayawada (Urban), Andhra Pradesh, 520002.

When was Imis Pharmaceuticals Private Limited incorporated?

Imis Pharmaceuticals Private Limited was incorporated on 25 June 1981.

Who are the current directors of Imis Pharmaceuticals Private Limited?

The current directors of Imis Pharmaceuticals Private Limited are

What is the primary industry of Imis Pharmaceuticals Private Limited?

The primary industry of Imis Pharmaceuticals Private Limited is Manufacturing.

Is Imis Pharmaceuticals Private Limited a listed company?

Imis Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Imis Pharmaceuticals Private Limited?

The authorized capital of Imis Pharmaceuticals Private Limited is ₹3.00 M, and the paid-up capital is ₹3.00 M.

What is the compliance status of Imis Pharmaceuticals Private Limited?

The compliance status of Imis Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available